$XBIO
Xenetic Biosciences Inc
PRICE
$0.8451 βΌ-2.063%
Last Close
VOLUME
84,871
DAY RANGE
0.8301 - 0.92
52 WEEK
0.4538 - 3.42
Join Discuss about XBIO with like-minded investors
@Chano #StockTraders.NET
now I'm glad I'm out π > @Chano said: starting to feel that I covered $XBIO too early
87 Replies 10 π 10 π₯
@TraderXx #StockTraders.NET
Same with $XBIO > @maletone said: damn was hoping $naov would hold
128 Replies 14 π 6 π₯
@TraderXx #StockTraders.NET
$XBIO gearing up to be a multi-day runner upwards IMO
52 Replies 13 π 12 π₯
@maletone #StockTraders.NET
have a feeling $XBIo will settlew back under vwap
60 Replies 13 π 8 π₯
@Chano #StockTraders.NET
judging by the volume from recent days, I think $XBIO is a liquidity trap move
50 Replies 8 π 7 π₯
Key Metrics
Market Cap
12.74 M
Beta
0.96
Avg. Volume
61.43 K
Shares Outstanding
14.32 M
Yield
0%
Public Float
0
Next Earnings Date
Next Dividend Date
Company Information
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCARTβ’, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCARTβ’ has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
Website: www.xeneticbio.com
HQ: 40 Speen St Ste 102 Framingham, 01701-1898 Massachusetts
Related News